ASH BIOMEDICAL INTEGRATED SERVICES LIMITED

Company Registration Number:
07643613 (England and Wales)

Unaudited statutory accounts for the year ended 31 May 2024

Period of accounts

Start date: 01 June 2023

End date: 31 May 2024

ASH BIOMEDICAL INTEGRATED SERVICES LIMITED

Contents of the Financial Statements

for the Period Ended 31 May 2024

Company Information - 3
Report of the Directors - 4
Profit and Loss Account - 5
Balance sheet - 6
Additional notes - 8
Balance sheet notes - 11

ASH BIOMEDICAL INTEGRATED SERVICES LIMITED

Company Information

for the Period Ended 31 May 2024




Director: Adetoyese Shodeinde
Registered office: 31
Marshall Close
Purley On Thames
Reading
England
RG8 8DQ
Company Registration Number: 07643613 (England and Wales)

ASH BIOMEDICAL INTEGRATED SERVICES LIMITED

Directors' Report Period Ended 31 May 2024

The directors present their report with the financial statements of the company for the period ended 31 May 2024

Principal Activities

The company's principal activity during the year continued to be wholesale of pharmaceutical goods.

Directors

The directors shown below have held office during the whole of the period from 01 June 2023 to 31 May 2024
Adetoyese Shodeinde

This report was approved by the board of directors on 25 October 2024
And Signed On Behalf Of The Board By:

Name: Adetoyese Shodeinde
Status: Director

ASH BIOMEDICAL INTEGRATED SERVICES LIMITED

Profit and Loss Account

for the Period Ended 31 May 2024


Notes

2024
£

2023
£
Turnover 180,445 183,146
Cost of sales ( 14,075 ) ( 2,728 )
Gross Profit or (Loss) 166,370 180,418
Administrative Expenses ( 108,274 ) ( 119,968 )
Operating Profit or (Loss) 58,096 60,450
Profit or (Loss) Before Tax 58,096 60,450
Tax on Profit ( 12,390 ) ( 7,204 )
Profit or (Loss) for Period 45,706 53,246

The notes form part of these financial statements

ASH BIOMEDICAL INTEGRATED SERVICES LIMITED

Balance sheet

As at 31 May 2024


Notes

2024
£

2023
£
Fixed assets
Tangible assets: 4 51,846 54,655
Total fixed assets: 51,846 54,655
Current assets
Debtors: 5 131,227 42,168
Cash at bank and in hand: 618 1,258
Total current assets: 131,845 43,426
Creditors: amounts falling due within one year: 6 ( 96,114 ) ( 40,936 )
Net current assets (liabilities): 35,731 2,490
Total assets less current liabilities: 87,577 57,145
Creditors: amounts falling due after more than one year: 7 ( 22,115 ) ( 37,389 )
Total net assets (liabilities): 65,462 19,756

The notes form part of these financial statements

ASH BIOMEDICAL INTEGRATED SERVICES LIMITED

Balance sheet continued

As at 31 May 2024


Notes

2024
£

2023
£
Capital and reserves
Called up share capital: 1 1
Profit and loss account: 65,461 19,755
Shareholders funds: 65,462 19,756

For the year ending 31 May 2024 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

This report was approved by the board of directors on 25 October 2024
And Signed On Behalf Of The Board By:

Name: Adetoyese Shodeinde
Status: Director

The notes form part of these financial statements

ASH BIOMEDICAL INTEGRATED SERVICES LIMITED

Notes to the Financial Statements

for the Period Ended 31 May 2024

  • 1. Accounting policies

    Basis of measurement and preparation

    These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

    Turnover policy

    Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services. Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have transferred to the buyer. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.

    Tangible fixed assets depreciation policy

    Tangible fixed assets are measured at cost less accumulative depreciation and any accumulative impairment losses. Depreciation is provided on all tangible fixed assets, other than freehold land, at rates calculated to write off the cost, less estimated residual value, of each asset evenly over its expected useful life, as follows:
    Fixtures, fittings, tools and equipment over 5 years

ASH BIOMEDICAL INTEGRATED SERVICES LIMITED

Notes to the Financial Statements

for the Period Ended 31 May 2024

  • 2. Employees


    2024

    2023
    Average number of employees during the period 4 4

ASH BIOMEDICAL INTEGRATED SERVICES LIMITED

Notes to the Financial Statements

for the Period Ended 31 May 2024

  • 3. Off balance sheet disclosure

    No

ASH BIOMEDICAL INTEGRATED SERVICES LIMITED

Notes to the Financial Statements

for the Period Ended 31 May 2024

4. Tangible assets

Office equipment Motor vehicles Total
Cost £ £ £
At 01 June 2023 18,697 82,607 101,304
Additions - - -
Disposals - - -
Revaluations - - -
Transfers - - -
At 31 May 2024 18,697 82,607 101,304
Depreciation
At 01 June 2023 15,888 30,761 46,649
Charge for year 2,809 - 2,809
On disposals - - -
Other adjustments - - -
At 31 May 2024 18,697 30,761 49,458
Net book value
At 31 May 2024 0 51,846 51,846
At 31 May 2023 2,809 51,846 54,655

ASH BIOMEDICAL INTEGRATED SERVICES LIMITED

Notes to the Financial Statements

for the Period Ended 31 May 2024

5. Debtors


2024
£

2023
£
Trade debtors 131,227 42,168
Total 131,227 42,168

ASH BIOMEDICAL INTEGRATED SERVICES LIMITED

Notes to the Financial Statements

for the Period Ended 31 May 2024

6.Creditors: amounts falling due within one year note


2024
£

2023
£
Trade creditors 55,365 12,213
Taxation and social security 25,538 13,512
Other creditors 15,211 15,211
Total 96,114 40,936

ASH BIOMEDICAL INTEGRATED SERVICES LIMITED

Notes to the Financial Statements

for the Period Ended 31 May 2024

7.Creditors: amounts falling due after more than one year


2024
£

2023
£
Bank loans and overdrafts 22,115 37,389
Total 22,115 37,389